Demonstration of an app-delivered digital therapeutic program for methamphetamine use disorder
Frontiers in Psychiatry · 13.07.2023 · 14
DOI: 10.3389/fpsyt.2023.1176641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 13.07.2023. Verfasst von Kristin Muhlner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Affect Therapeutics, Inc., New York, NY, United States. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study assessed the feasibility and utility of a digital, all-virtual program designed for treatment of methamphetamine use disorder (MUD). Forty-nine adults with moderate- to severe-level MUD (per DSM-5 criteria) commenced the 8-week intervention. All aspects of the program were delivered via smartphone-based app. Intervention components included counseling (cognitive behavioral therapy in group and individual sessions), app-based therapeutic tasks, remote biological drug testing, medical oversight by psychiatrists/nurse practitioners, and contingency management procedures (including rewards for methamphetamine-free saliva drug tests, accomplishing tasks, and engaging in assigned activities). Of the 49 participants who commenced treatment, 27 participants (55%) completed the program. Repeated-measures mixed-model analyses show that participants were more likely to test negative for meth use from week 1 to week 8 (OR = 1.57, 95% CI [1.28, 1.97]; p = 0.034). Well-being and social functioning improved among the majority of participants. These results demonstrate the utility of the all-virtual, digital therapeutic program and its ability to help individuals with MUD to reduce or cease methamphetamine use. The program was efficiently implemented and was well received by participants and clinical personnel, indicating its ability to deliver comprehensive, effective care and to retain the difficult-to-engage population of persons with MUD. Of the 27 completers, 16 responded to a 1-month follow-up survey and reported no meth use in the month since completing the program.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affect Therapeutics, Inc., New York, NY, United States.
- UCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA, United States.
- Treatment Research Institute, Research Park, NC, United States.
Zitieren
APA
Muhlner, K., DeFlavio, J., Ang, A., Zito, M., McLellan, A. T., & Perrochet, B. (2023). Demonstration of an app-delivered digital therapeutic program for methamphetamine use disorder. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1176641
Vancouver
Muhlner K, DeFlavio J, Ang A, Zito M, McLellan AT, Perrochet B. Demonstration of an app-delivered digital therapeutic program for methamphetamine use disorder. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1176641
BibTeX
@article{Muhlner2023,
author = {Muhlner, Kristin and DeFlavio, Jeff and Ang, Alfonso and Zito, Michael and McLellan, A Thomas and Perrochet, Brian},
title = {Demonstration of an app-delivered digital therapeutic program for methamphetamine use disorder},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1176641}
}
EUVIMED